Non Medical Independent And Supplementary Prescribing V300 Nursing Essay

Non health check Independent And Supplementary Prescribing V300 Nursing EssayThis essay discusses the evolution of lactate prescribing in the context of legislation and political element, with the consideration of how this has changed and assisted the clinical nurse specialist design, with positi scarcely emphasis on pump reverse. The pathophysiology of partiality and soul nonstarter will be discussed and integ considerd into the relation of drug actions with particular interest into Diuretics. Alongside this the importance of effective history taking, assessment and cite skills to treat the affected role accurately and at a high pattern and quality is discussed. The decision make process and the importance of a dual-lane access code in relation to midsection disappointment is highlighted incorporating the importance of accord in the maximising the discourse of centerfield disaster.Sources of information and decision condescend systems that ar availcapable wil l be highlighted with a discussion on the importance of these in article of faiths. Demonstration of ability to enjoin unhurtly, ration each(prenominal)y, cost effectively, and in consideration of the cosmos health issues around medicine consumption atomic account 18 discussed and fin on the wholey clinical governance through quality assertion and analyse of prescribing execute is considered.For the purpose of the essay the following learning outcomes argon discussed respect understanding and application of the relevant legislation and political context of the practice of non- aesculapian examination prescribingCritic on the wholey appraise sources of information/advice and decision support systems in prescribing practice and support the principles of evidence lay downd practice to decision making.Integrate and apply knowledge of drug actions in relation to pathophysiology of the condition being handleDemonstrate the ability to prescribe safely, rationally, cost effec tively, and in consideration of the public health issues around medicines useIntegrate a overlap near to decision making taking account of perseverings/c atomic number 18rs wishes, values, religion or genialisationEvaluate effective history taking, assessment and consultation skills with perseverings/clients, parents and carers to inform work / contrastingial diagnosing.Contribute to clinical governance through quality assurance and analyse of prscribing practice and regular continuing professional developmentThe controls of medicines in the UK has undergone a number of regulatory changes since the end of 1800s, climaxing in the Medicines Act (1968). previous to 1992, doctors, veterinary surgeons and dentists were the all professions legally permitted to prescribe. This situation made the medical profession gatekeepers for medicines, certainly the case for those medicines considered more(prenominal) likely to cause harm or abuse such as controlled drugs i.e. morphine.Cu mberledge Report (1986) identified the posit for companionship nurses to prescribe, The Crown Report (1989) published findings of a review to determine the plenty in which non-medical health professionals could undertake invigorated roles with regard to prescribing, supply and administration of medicines and led to the development of protocols which we now know as Patient conference Directives (PGDs).The Crown Report (1999) commended that legal authority to prescribe should be widen to include new groups of healthcare professionals, this also bought about the antitheticiation amidst Independent and Supplementary prescribers. This report noted that a doctor a lot rubber stamps a prescribing decision taken by a nurse, which is humiliating to nurses and doctors. (Cooper et al,2008)The Medicinal Products Act (1992) permitted fitted District keeps and Health Visitors to independently prescribe, and this was only a limited number of medicines from a Community practicians For mulary.Over the following(a) a few(prenominal) course of studys legislative changes occurred which involved, non community qualified nurses to train as prescribers, together with an increase in medications added to the Nurses Formulary. In 2003, nurses and Pharmacists were permitted to prescribe from the whole of the British topic Formulary (BNF) as supplementary Prescribers, except controlled and unlicensed drugs. Controlled Drugs were prescribable by nurses and pharmacists using supplementary prescribing from 2005. During this time separate allied Healthcare professionals such as physi differentapists, Radiographers, Podiatrists and optometrists were also able to work supplementary prescribers. (DOH, 2005)These rapid changes in the development of non medical prescribers in the fall in Kingdom were a parentage to the gradual introduction to prescribing rights in the United States of America. (Armstrong,1995). The UK now has the or so increase non medical prescribing right s in the world. (Armstrong, 1995) In 2006, DOH (2006) permitted trained nurses and pharmacists to independently prescribe all medicines within their clinical competence. The most recent changes set about occurred to the damage of Drugs Regulations (2012) which now means that arrogately qualified nurses and pharmacists will be able to prescribe controlled drugs like morphine, diamorphine and prescription strength co-codamol.Currently in that respect are more than 50,000 Non medical prescribers in the UK, around 19,000 nurses and almost 2,000 pharmacists are qualified as Independent and/or supplementary prescribers (Carey, 2011)The changing legislation of Non medical Prescribers has changed alongside with the environment of the NHS operate. This is recognised in the lookout produced by NMC (2010) stating that the services delivered by the NHS become more challenging and complex as there is an ever change magnitude need for improved productivity without the compromising of qual ity.coronary heart disease, puts great compact and demands on the National Health returns (NHS). Hospital admissions for Chronic kindling failure have increased markedly, continuing fondness failure accounts for about 5% of all medical admissions and more or less 2% of total health care expenditure. Despite improvements in medical instruction, under sermon for flavour failure is still common. (Mcmurray et al, 2002) In 2002, The British nerve center Foundation (BHF) piloted a scheme and funded with the help of Big drafting Fund ninety both disembodied spirit failure nurses throughout the United Kingdom. The results were shown in the final report BHF (2008) showing an average reduction in heart failure admissions of 43% and an average estimated saving, per heart failure uncomplaining of 1, 826. Increasing the role of the Non medical prescribers indeed increasing the skills and knowledge of nurses/pharmacists only enhances the vital role within the field these nurses ha ve in to daytimes current fight to stick out the highest quality care possible. It has been shown that registered nurses are extending their roles and responsibilities to work in new ways (Furlong + smith, 2005). Crowther et al (2003), Gattis et al (1999), Paniagua (2011) Lambrinou et al (2012) and Jaarsma (2010) have all shown that Heart failure nurse specialists are optimal translaters to assist physicians with Heart failure care for this complex and time-consuming patient population.The steering of heart failure is complex involving two pharmacological interventions and strategies to improve patients run lowal situation and quality of life (Palmer et al, 2003) Heart failure can be outlined as an abnormality of cardiac structure or function prima(p) to failure of the heart to deliver oxygen at a rate commensurate with the requirements of the metabolizing tissues. (ESC, 2012)Clinically patients present with typical symptoms glimmerlessness, ankle swelling and fatigue. And signs advance JVP, pneumonic crackles and displaced eyeshade beat. Diagnosis of heart failure relies on a detailed history and accurate physical examination (NICE, 2010). These symptoms can be related to either a reduction of cardiac ourput (fatigue) or to lavishness fluid belongings (dysapnea, orthopnea and cardiac wheezing) fluid retention also results in circumferential oedema and occasionally an increasing abdominal girth petty(a) to ascites. Symptoms and signs are often non-specific and could be related to different conditions. Knowledge on the use of other diagnostic services is necessary Echocardiography, Electrograph, authority Xray, parenthood tests all contribute to the confirmation of diagnosis.Case case One demonst judge a typical presentation of a patient presenting with offshoot presentation of heart failure symptoms typically compromised and in need of expert medical intercession Pharmacological and non pharmacological therapies. This patient presented with clear signs of congestion and volume retention of which a diuretic therapy plays a central role in the treatment (Felker and Mentz, 2012)As the heart fails, there is a reduction in both blood pressure and cardiac output, in response to this the body maintain water which results in oedema. Diuretics act at different sites of the kidneys, they then deflect sodium and water through enhanced excretion from the kidneys so are able to relieve the symptoms of fluid congestion. Different classes of diuretics work at different establishs within the kidney tubules. (Davies et al, 2000) Appendix two shows the diuretics available.This patient was treated with Furosemide intravenously (IV), most patients receive a wave diuretic as first line treatment for heart failure (Faris et al, 2012.) Loop diuretics are the most frequently apply diuretic in treatment of Chronic heart failure despite their unproven effect on survival, their indisputable aptitude in relieving congestive symptoms m akes them first line therapy for most patients. (Bruyne, 2003) Appendix trinity shows how loop diuretics work.As already stated first line treatment for vivid decompensated heart failure is intravenous diuretic therapy either as a bolus or via continuous infusion. Despite being available for decades, few randomized trials exist to guide dosing and administration of this drug. In 2011, the Diuretic optimisation Strategies military rating (DOSE) trial used a prospective, randomized design to equivalence bolus versus continuous infusion of IV furosemide, as well as high- do drugs versus low-dose therapy. The study embed no divergence in the primordial end point for continuous versus bolus infusion. High-dose diuretics were more effective than low dose without clinically in-chief(postnominal) negative effects on renal function. Although no difference was found between IV and bolus dose there are bring ins to both elements so clinical judgement would be made on the specific pati ent needs and requirements, for example, immobilization, duration of therapy requirements, haemodynamic status. The point of using diuretics is to achieve and maintain euvolaemia (the patients modify weight with the lowest achieveable dose. (ESC, 2012).Case study two identifies a patient whom is another example of heart failure but offers a different presentation this accentuates the importance of a careful physical examination and important accurate history taking. The absent breathe sounds over the right base of lung field along with the history was an extension of pleural effusion and initiated the prescription of a radiograph chest to be performed. Absent or emaciated breath sounds strongly suggest an effusion (Kalantri et al, 2007) unfortunately Congestive heart failure is the most common cause of a pleural effusion. (Enrique, 2008) Again, pleural effusions from heart failure are managed with diuretic therapy, initially with a loop diuretic, intravenously titrated in respo nse to clinical signs, daily weights and renal function to avoid excessive volume depletion. (Light, 2002)Non-compliance in patients with heart failure (HF) contributes to deterioration HF symptoms and may lead to hospitalization. (Van der wal, 2006). Using skills that were taught during basic nursing gentility is imperative in conducting a beneficial and effective clinical examination, these social skills may dictate how the patient and carers perceive and acknowledge there diagnosis and may have an influence on the burn up the patient has on his/her own health.Over the then(prenominal) 3 decades, the biopsychosocial mold of health has become increasingly important in the effective practice of medicine. Central to this model is an emphasis on treating the patient as a whole person, including the biological, psychological, behavioral, and social aspects of their health (Engel, 1980). The American Heart acquaintance (AHA) in collaboration with other professional societies has issued a new scientific instruction for the centering of patients with groundbreaking heart failure. It emphasizes shared decision making and is designed to help physicians and other health professionals align medical treatment options with the wishes of the patients. Allen (2012) recognises the complexity of heart failure and complexity of the treatment options can be a barrier to shared decision making, but this only emphasizes why such a patient-centred attempt should be undertaken in Advanced heart failure. Shared decision making has received particular emphasis in relation to the prescribing of drug treatments. Traditionally, studies have identified 50% of patients with chronic conditions do not take their treatment as prescribed, with major reasons being because they do not share the doctors views, or they are worried about side effects. (REF QUOTE?) Therefore the aim is to explore these issues by adopting a shared decision making approach and reach a concordance between do ctor and patients.Therefore getting patients involved in the programmening and management of care, being sensitive to the individuals need, consumption time figuring out what is important to them, will hopefully narrow some of the confusion and complexities concerning heart failure. Although knowledge alone does not encounter compliance, patients can only comply when they possess some minimal train of knowledge about the disease and the health care regimen. (Van der wal, 2006).The National Prescribing marrow squash (2012) designed a competency framework which can be seen in appendix 3. One of the three domains is the consultation which highlights three areas of importance 1 Knowledge pharmacological and pharmaceutical. 2 Options concerning the diagnosis and management 3 strength involving shared decision making with parents, patients and carers. The entropy is clear that for the benefit of the patient and success with the treatment regimen it is vital to consider wishes of the patient/carer, ethical, ethnical opinions, lifestyle of the patients. Also contributing factors which may cause non-complicance whether intentional or not for example polypharmacy, complicated dose regimens, unpleasant side effects, and cognitive problems or physical disability preventing the patient taking the medicines. A bighearted number of factors need to be incorporated into the thought process front to getting to the point and writing a prescription.Surrounding issues that directly and indirectly support patient orientated prescribingSources of information are on number of levels. In a hospital ward, for example, immediate sources of information include the British National Formulary (BNF) and ward pharmacist. The role of both is, at least in part, to assist in ensuring that, for either prescription, the correct dose and time of administration are correct and appropriate for the indication. The BNF is widely available and complaisant and can and should be used to ass ist in prescribing whenever there is any doubt about dose and timing. The Pharmacist provides an additional safety netting, by checking prescriptions before providing the medications. In addition, the pharmacists role includes ensuring that medications prescribed are available for administration. encourage afield, but still within the hospital, topical anaesthetic policies lead advocate on what drugs are available and recommended for a particular indication. These policies may be produced by the hospital or by regional bodies, including SHA, Network PCTs, for example, local order may mean that a particular statin is used for primary prevention of coronary heart disease, due to local procurement agreements or cost effectiveness analyses.Beyond the hospital setting, a number of sources provide guidance on what should actually be prescribed, or considered, for a assumption condition. Such sources might include national bodies, in particular National institute of clinical excellenc e (NICE) and specialist societies. The latter may be national and or international. For example, in the field of heart failure, NICE has given guidance on what medications should be administered and at what stage of the disease and symptoms. For all patients ACEI should be given. There are many different ACE I. The guidelines recommend using only those which have actually been proven to be of benefit in heart failure these emailprotected. For those who are intolerant of ACE arbitrager should be used. Again, NICE recommends thoses that have shown efficacy in clinical trials, and these emailprotected. Beta-blockers are recommened but not any betablocker. Only those with proven in heart failure should be used these are Aldosterone Antagonists should also be used for patients with right heart failure (NYHA III/IV). Guidance recommends spironolactone, or eplernone if not tolerated (most normally due to gynaenomastia in men)From the above, it may be seen that the National guidance ind icates which drugs from each class should be considered for each purpose. This leaves room for local policies and prescribers to get back which of the available agents is suited for a particular individual.Pursuing the example of heart failure further, international guidelines are issued by a number of bodies. The principle of these is the European smart set of Cardiology (ESC) and the American College of Cardiology (ACC) and the American Heart Association (AHA). Of these, the ESC guidelines are most applicable to the United Kingdom. Societal guidelines tend to focus more on a particular disease and the available evidence to provide best treatment, whereas NICE guidelines have greater emphasis on judgement of cost-effectiveness, which is of greater relevance to the local health economy in the UK. Furthermore, ESC guidelines give a strength of recommendation for a particular treatment (Class I, IIa, IIb) and an indication of the level of evidence behind the recommendation. (A, B, C)Ultimately, the source of information which informs societal guidelines comes from research, in the form of clinical trials, performed on the back of pre-clinical research. Therefore, the doses of drugs which are recommended for use usually reflects the dose and frequency of a drug or used in a clinical trial which demonstrated benefit.There are therefore numerous levels of information and advice which support prescribing practice. For many conditions, these are ultimately base on evidence derived from clinical trials, in some areas these will be the gold standard RCT. However, some trials provide softer evidence, such as observations data or even anecdotal. Understanding of these various trials and guidelines is important to understanding how local guidelines and daily prescribing practice come about and are supported by evidence.The trials/guidelines all mentioned above have provided convincing evidence that clinically strong improvements can be achieved in heart failure by a ppropriate drug treatment. Moynihan et al (2002) recognises that the adoption of more effective and/or safer drugs, new technologies are usually more expensive, aging of the population leads to increased unwholesomeness and drug therapy, all play a role in increasing drug expenditure.Medicines are regarded an expenditure, but can also be an coronation, if they are used rationally. Rational prescribing means cost effective use of safe and effective drugs.Specialist clinics for heart failure are a shit for delivering care according to clinical guidelines and providing diagnostic treatment. They provide optimal management of the condition, education of patient and carers about the signs and symptoms of worsening disease and medication compliance. Advances in medication and technology for heart failure are vast, which again strengthens the need and importance of such clinics to enable patient treatment to change whence and fitly. Studies have shown that if patients are treated by Ca rdiology clinicians or Heart failure specialist nurses, clinical guidelines are more likely to be followed and readmission rates are lower for these patients. (Reis et al, 1997)An example of prescribing within heart failure is an investment for the patient and the NHS is the use of Angiotensin-converting enzyme inhibitors (ACE I). These have been shown to improve symptoms, survival and slow cash advance of heart failure. (Luzier et al, 1998). ACE I are one of the essential therapies for all heart failure patients, if tolerated. Treatment should be maximised and in maximising the dose quite often you can reduce or part with the use of loop diuretics due to improved symptoms and clinical signs. (Hoyt et al, 2001) Therefore patients who are appropriately treated and titrated to maximal therapy therefore benefit clinically, may reduce other medicines and they can overall reduce the chances of hospital admission with decompensated heart failure which is beneficial to the patient and th e NHS finances.A recent study by Dharmarajan et al (2013) covering three million hospitalizations showed that more than a third of readmissions (within 30 days of discharge) were for heart failure. Their thought was that many of these could have been preventable, with greater introduce from pharmacists, physicians, nurse specialists, and greater consideration to social elements reducing readmission also reduces other risks involved in exposing patients to hospitalization. The National Heart failure Audit (2012) conducted by NICOR is an audit to monitor progress, clinical findings and patient outcomes of patients with heart failure. It is an essential audit for each NHS trust to comply and complete. ++. It provides critical information on management and outcomes which then provides data essential to drive future improvements.Conclusion discipline STUDY ONEDescription of clinical settingPatient was an inpatient on the Cardiology ward he was admitted the day before and had been refer red to Heart failure clinical nurse specialist for review.Case historyAn 84 year old retired postman was admitted from home with progressive worsening shortness of breath over the last 6 weeks. He had been to see the General Practitioner two weeks ago who treated him for a chest infection with a course of oral antibiotics (Amoxycillin). He denies any chest pain, however he complains of palpitations at times of exertion and a productive cough. Patient had not experienced any syncope, dizzy spells only other complaint was button of appetite and poor quality sleep. Patient has been sleeping with 4 pillows, wakeful regularly due to struggling for breathe and resulted to sleeping in the top downstairs. Exercise tolerance had drastically reduced to 50 metres before having to stop due to breathlessness.On examination the patient was tachypnoeic, pulse was 95 and regular, academic session blood pressure was 110/62 standing 105/55. weight 97kg. Oxygen Saturations on air 94%. Inspiratory crackles were clearly perceive on both lung bases, no heart murmur could be auscultated and apex beat was misplaced to the anterior auxiliary line. JVP was raised +4. Pitting peripheral oedema up to thighs and a large distended abdomen, which was soft and not bidding on palpation. ECG confirmed Sinus tachycardia with Q waves in antero lateral leads. Chest x-ray also confirmed cardiomegaly and interstitial oedema.Drug treatment pre admission acetylsalicylic acid 75mg once a day (OD)Blood pressure controlPast medical historyAnterior lateral myocardial infarction 7 years ago (2005) followed by Angioplasty to the right coronary artery.No further operations or admission to hospital.Blood results chemical science Sodium 128mmol/l, Potassium 4.8 mmol, Urea 9 mmol/l, Creatinine 145 mmol/l, LFTs, HB and clot was all unremarkable.Echosevere left ventricular dysfunction, with minor tricuspidate regurgitation.Social backgroundPatient lives with wife in a two bedroom bungalow, they are both normally well and independant. He has no allergies and takes no over the counter medications or recreational drugs in the past or present.Drug chart to date in hospitalAspirin 75mg ODFrusemide 80 mg ODRamipril 2.5 mg OD discoursePatient was fortunate enough to have had Echocardiography that morning, which offered me the definitive diagnosis. This gentleman presents with a common clinical presentation of progressive systolic dysfunction of an ischemic cause. The patient was comfortable and stable enough for a steady and organized examination and history taking.On construction of a management plan for this patient, clearly first line treatment is diuretic therapy, T telling dieresis and consequent adjustment of the loading conditions of the failing heart is more often than not regarded as essential (Raftery, 1994)This patient went on to be prescribed endovenous Diuretics, instructions for Daily weights, Fluid balance, advice and rehabilitation for heart failure. Then seven-day te rm plan for titration of Heart failure medications to achieve maximum therapy suitable for this patient.Allen, L.A., Stevenson, L.W., Grady, K.L., Goldstein, N.E., Matlock, D.D., Arnold, R.M., Cook, N.R., Felker, G.M., Francis, G.S., Hauptman, P.J., Havranek, E.P., Krumholz, H.M., Mancini, D., Riegel, B. and Spertus, J.A., for the American Heart Association Council on Quality of Care and Outcomes explore Council on cardiovascular Nursing Council on Clinical Cardiology Council on Cardiovascular Radiology and Intervention Council on Cardiovascular Surgery and Anesthesia, 2012. Decision making in advanced heart failure a scientific statement from the American Heart Association. Circulation, 125(15), pp.1928-1952.Armstrong, P., McCleary, K. J. and Munchus, G., 1995. Nurse practitioners in the USA their past, present and future. just about implications for the health care management delivery system. Health Manpower focal point, 21(3), pp.3-10.Avery, A.J. and Pringle, M., 2005. protr acted prescribing by UK nurses and pharmacists. British Medical daybook, 331, pp.1154-1155.Bruyne, L.K., 2003. Mechanisms and management of diuretic resistance in congestive heart failure. Postgraduate Medical Journal, 79(931), pp.268-271.Carey, N. and Stenner, K., 2011. Does non-medical prescribing make a difference to patients? Nursing Times, 107(26), pp.14-16.Cooper, R., Guillaume, L., Avery, T., Anderson, C., Bissell, P., Hutchinson, M., Lynn, J., Murphy, E., Ward, P. and Ratcliffe, J., 2008. Non medical prescribing in the United Kingdom developments and stakeholder interests. Journal of ambulant Care Management, 31(3), pp.244-252.Crowther, M., 2003. Optimal management of outpatients with heart failure using advanced practice nurses in a hospital-based heart failure centre. Journal of the American Academy of Nurse Practitioners, 15, pp.260-265.Davies, M.K., Gibbs, C.R. and Lip, G.Y., 2000. ABC of heart failure. Management diuretics, ACE inhibitors and nitrates. British Medical Journal, 320(7232), pp.428-431.Department of Health and Social Security, 1986. Neighbourhood nursing a focus for care (Cumberledge report) London, HMSO.Department of Health, 1989. Report of the Advisory Group on Nurse Prescribing (Crown report) London, HMSO.Department of Health, 2000. National Service Framework for Coronary Heart Disease. London, HMSO.Department of Health, 2005. Supplementary prescribing by nurses, pharmacists, chiropodists/podiatrists, physiotherapists and radiographers within the NHS in England. A guide for implementation. London, HMSO.Department of Health, 2006. Improving patient access to medicines A guide to implementing Nurse and Pharmacists independent prescribing within the NHS in England. London, HMSO.Dharmarajan, K., Hsieh, A.F., Lin, Z., Bueno, H., Ross, J.S., Horwitz, L.I., Barreto-Filho, J.A., Kim, N., Bernheim, S.M., Suter, L.G., Drye, E.E. and Krumholz, H.M., 2013. Diagnosis and timing of 30 day readmissions after hospitalization for heart failure, a cute myocardial infarction, or pneumonia. Journal of American Medical Association, 309, pp.355-363.Diaz-Guzman, E. and Budev, M., 2008. Accuracy of the physical examination in evaluating pleural effusion. Cleveland Clinic Journal of Medicine, 75(4), pp.297-303.Faris, R.F., Flather, M., Purcell, H., Poole-Wilson, P.A. and Coats, A.J., 2012. Diuretics for heart failure. Cochrane Database of Systematic Reviews, Issue 2. Art. No. CD003838. DOI 10.1002/14651858.CD003838.pub3.Felker, G.M., Lee, K.L., Bull, D.A., Redfield, M.M., Stevenson, L.W., Goldsmith, S.R., LeWinter, M.M., Deswal, A., Rouleau, J.L., Ofili, E.O., Anstrom, K.J., Hernandez, A.F., McNulty, S.E., Velazquez, E.J., Kfoury, A.G., Chen, H.H., Givertz, M.M., Semigran, M.J., Bart, B.A., Mascette, A.M., Braunwald, E., OConnor, C.M., for the NHLBI Heart bereavement Clinical Research Network, 2011. New England Journal of Medicine, 364(9), pp.797-805.Felker, G.M. and Mentz, R.J., 2012. Diuretics and ultrafiltration in acute decompe nsated Heart failure. Journal of the American College of Cardiology, 59(24), pp.2145-53.Furlong, E. and Smith, R., 2005. Advanced nursing practice. Policy, education and role development. Journal of Clinical Nursing, 14, pp.1059-1066.Gattis, W.S., Hasselbied., V., Whellan, D.J. and OConnor, C.M., 1999. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team. Archives of Internal Medicine, 159, pp.1939-1945.Hawkins, N.M., Petrie, M.C., Jhund, P.S., Chalmers, G.W., Dunn, F.G. and McMurray, J.J., 2009. Heart failure and chronic obstructive pulmonary disease diagnostic pitfalls and epidemiology. European Journal of Heart Failure, 11, pp.130-139.Hoyt, R.E. and Bowling, L.S. 2001. Reducing readmission for congestive heart failure American Family Physician, 63(8), pp.1593-1598.Hunt, S.A., Baker, D.W., Chin, M.H., Cinquegrani, M.P., Feldman, A.M., Francis, G.S., Ganiats, T.G., Goldstein, S., Gregoratos, G., Jessup, M.L., Noble, R.J., P acker, M., Silver, M.A., Stevenson, L.W., Gibbons, R.J., Antman, E.M., Alpert, J.S., Faxon, D.P., Fuster, V., Gregoratos, G., Jacobs, A.K., Hiratzka, L.F., Russell, R.O. and Smith, S.C. Jr American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) International Society for Heart and Lung Transplantation Heart Failure Society of America, 2001. ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) Developed in collaboration with the International Society for Heart and Lung Transplantation Endorsed by the Heart Failure Society of America. Circulation, 104(24), pp.2996-3007.Jaarsma, T., 2010. Multidisciplinary approach in heart failure evidence, experiences and challenges. Journal of Cardiac Failure, 16(9), pp.1071-9164.Kalantri, S., Joshi, R. and Lokhande, T., 2007.